data_2cef_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cef _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 110.625 -0.139 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 4.5 p-90 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.9 p-90 . . . . . 0 CA--C 1.55 0.962 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.4 p-90 . . . . . 0 CA--C 1.555 1.158 0 N-CA-C 111.035 0.013 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.434 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.5 p-90 . . . . . 0 CA--C 1.551 0.989 0 CA-C-O 119.958 -0.067 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.5 p-90 . . . . . 0 CA--C 1.551 0.998 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.452 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.2 p-90 . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.3 p-90 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 110.69 -0.115 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 2.6 p-90 . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.045 0.45 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 2.8 p-90 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.457 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.6 p-90 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.97 -0.011 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 119.463 -0.303 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -80.64 -54.04 6.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.298 1.039 . . . . 0.0 112.865 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -91.91 -40.52 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.319 1.047 . . . . 0.0 112.51 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.32 156.21 25.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.985 1.714 . . . . 0.0 110.625 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -141.29 58.4 1.52 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 4.5 p-90 -159.97 -104.12 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.34 2.656 . . . . 0.0 109.142 -169.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 70.54 76.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.1 -23.48 33.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.612 2.208 . . . . 0.0 114.131 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.9 -81.9 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.111 0.965 . . . . 0.0 111.185 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 177.31 -51.37 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.168 2.187 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.83 -45.78 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.545 0.738 . . . . 0.0 111.663 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.175 1.39 . . . . 0.0 111.882 179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 170.81 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 128.42 2.688 . . . . 0.0 111.184 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -64.64 169.52 4.88 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.159 1.384 . . . . 0.0 113.496 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -9.51 99.52 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 129.309 3.044 . . . . 0.0 115.441 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -153.64 70.28 0.83 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.9 p-90 -167.5 -154.05 0.15 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.382 2.673 . . . . 0.0 110.354 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 81.86 101.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.8 172.5 14.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.187 3.258 . . . . 0.0 112.039 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.83 -50.17 1.24 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.184 0.994 . . . . 0.0 113.632 -176.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 142.76 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 130.921 3.688 . . . . 0.0 112.018 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.4 t -63.47 -35.61 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.551 0.614 . . . . 0.0 110.306 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.253 1.238 0 C-N-CA 127.296 2.238 . . . . 0.0 111.529 169.408 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 111.374 0.139 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 70.35 6.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.621 1.169 . . . . 0.0 111.054 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -160.05 161.23 33.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.666 1.587 . . . . 0.0 112.56 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.36 -32.67 74.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 50.84 54.62 10.9 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.4 p-90 -161.39 -154.87 0.37 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.503 2.321 . . . . 0.0 111.035 -168.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 76.46 86.3 0.08 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -86.45 -23.3 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.302 2.668 . . . . 0.0 114.639 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -72.58 -69.64 0.39 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 57.42 34.4 24.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.835 1.654 . . . . 0.0 112.935 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.09 -39.42 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.899 0.88 . . . . 0.0 110.959 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 126.172 1.789 . . . . 0.0 113.686 172.084 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -164.03 -57.94 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.069 1.347 . . . . 0.0 111.516 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -87.42 164.59 16.11 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.952 1.301 . . . . 0.0 112.356 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.24 -0.67 57.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.112 1.365 . . . . 0.0 114.297 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -147.49 92.26 2.07 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.434 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.5 p-90 -137.45 -151.01 0.38 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.531 2.332 . . . . 0.0 111.178 -169.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -164.99 56.62 0.12 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 -49.22 2.3 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.178 1.918 . . . . 0.0 112.31 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 tp -175.97 116.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.049 2.14 . . . . 0.0 108.72 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -71.78 -15.95 62.18 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.8 -24.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.891 1.276 . . . . 0.0 111.857 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.477 1.911 . . . . 0.0 113.091 -175.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 76.77 -51.04 0.57 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 128.574 2.75 . . . . 0.0 112.881 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.29 -32.19 0.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.932 2.893 . . . . 0.0 115.529 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.31 -29.99 70.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.16 1.384 . . . . 0.0 114.388 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 9' ' ' SEP . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 61.21 51.99 4.11 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . 0.437 ' H ' HG12 ' A' ' 6' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.5 p-90 -163.63 -156.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.022 2.529 . . . . 0.0 110.481 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 68.7 97.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.36 157.61 37.05 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.312 2.674 . . . . 0.0 111.529 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.7 tp -152.43 -94.88 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.799 1.239 . . . . 0.0 109.406 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -172.7 -46.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.864 1.666 . . . . 0.0 112.84 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.89 -35.34 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.841 0.856 . . . . 0.0 112.546 -174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 126.854 2.062 . . . . 0.0 114.642 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.293 36.7 ptt180 43.19 40.35 2.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.817 2.447 . . . . 0.0 117.086 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -132.91 38.48 3.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.26 1.824 . . . . 0.0 112.591 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 79.68 -4.29 1.98 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.378 2.671 . . . . 0.0 115.238 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 67.39 50.57 0.94 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.452 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.2 p-90 -163.25 -151.11 0.17 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.45 2.3 . . . . 0.0 111.172 -171.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 74.52 -59.15 0.56 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.46 -53.48 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.891 2.394 . . . . 0.0 111.777 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.2 107.44 0.51 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 108.734 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -101.99 23.59 11.28 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.586 1.554 . . . . 0.0 112.641 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t 90.44 -20.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 130.141 3.376 . . . . 0.0 111.462 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.452 1.901 . . . . 0.0 114.177 178.175 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.523 -0.275 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -134.66 136.37 42.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.665 1.586 . . . . 0.0 111.436 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -129.8 59.0 1.62 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.837 1.655 . . . . 0.0 111.555 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.69 69.96 0.45 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.474 1.91 . . . . 0.0 113.105 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 57.96 47.72 14.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 3.3 p-90 -162.21 -157.4 0.47 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.069 2.548 . . . . 0.0 110.69 -170.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -51.59 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.04 123.12 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.539 2.826 . . . . 0.0 111.408 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.7 mt -117.54 -93.46 0.51 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.65 1.18 . . . . 0.0 108.712 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -166.85 47.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.159 2.583 . . . . 0.0 109.706 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.92 -26.08 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.28 -0.888 . . . . 0.0 111.875 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.239 1.416 . . . . 0.0 112.921 -176.247 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -66.34 140.71 58.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.352 1.061 . . . . 0.0 112.874 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -163.62 -49.67 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.494 1.918 . . . . 0.0 112.585 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.99 -30.8 9.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.943 1.297 . . . . 0.0 113.984 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -137.03 63.51 1.56 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 2.6 p-90 -163.15 -124.31 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.885 2.074 . . . . 0.0 110.882 -169.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 104.75 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.81 -37.5 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.031 2.487 . . . . 0.0 113.667 -170.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp 73.74 112.45 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.066 2.546 . . . . 0.0 111.339 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -109.32 25.23 12.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -65.81 -36.29 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.365 1.866 . . . . 0.0 111.591 -177.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 70.01 -48.32 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 128.64 2.776 . . . . 0.0 114.571 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -139.78 32.27 2.02 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.652 1.581 . . . . 0.0 113.304 -170.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 95.35 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.741 3.616 . . . . 0.0 111.657 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -134.66 58.21 1.78 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 2.8 p-90 -167.8 -153.82 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.236 2.614 . . . . 0.0 110.44 -169.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -74.46 76.49 1.93 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.04 -57.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.93 2.42 . . . . 0.0 113.207 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -164.89 -56.64 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.019 0.928 . . . . 0.0 111.792 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 64.36 55.43 1.41 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.716 1.606 . . . . 0.0 112.05 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.51 -41.82 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.076 0.95 . . . . 0.0 111.054 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.532 1.933 . . . . 0.0 113.219 175.675 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -109.73 143.85 38.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.372 1.469 . . . . 0.0 111.229 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.48 -41.38 39.7 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.174 0.59 . . . . 0.0 112.5 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.0 168.14 10.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.957 1.303 . . . . 0.0 111.365 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -134.68 48.76 2.28 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.457 ' CE3' ' HG2' ' A' ' 11' ' ' LYS . 5.6 p-90 -160.14 -157.31 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.703 2.401 . . . . 0.0 110.97 -172.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -48.98 107.66 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.59 -23.75 5.68 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.549 2.833 . . . . 0.0 114.154 -169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.43 -126.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.148 1.779 . . . . 0.0 108.387 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -52.57 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.073 1.749 . . . . 0.0 112.318 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.25 -34.67 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.67 1.188 . . . . 0.0 111.837 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.346 1.859 . . . . 0.0 111.902 -171.031 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 110.625 -0.139 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 4.5 p-90 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.474 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.9 p-90 . . . . . 0 CA--C 1.55 0.962 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.4 p-90 . . . . . 0 CA--C 1.555 1.158 0 N-CA-C 111.035 0.013 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.5 p-90 . . . . . 0 CA--C 1.551 0.989 0 CA-C-O 119.958 -0.067 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.5 p-90 . . . . . 0 CA--C 1.551 0.998 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.2 p-90 . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 3.3 p-90 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 110.69 -0.115 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 2.6 p-90 . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.045 0.45 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 6' ' ' VAL . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 2.8 p-90 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 5.6 p-90 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.97 -0.011 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 119.463 -0.303 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -80.64 -54.04 6.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.298 1.039 . . . . 0.0 112.865 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -91.91 -40.52 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.319 1.047 . . . . 0.0 112.51 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -115.32 156.21 25.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.985 1.714 . . . . 0.0 110.625 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -141.29 58.4 1.52 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 4.5 p-90 -159.97 -104.12 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.34 2.656 . . . . 0.0 109.142 -169.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 70.54 76.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.1 -23.48 33.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.612 2.208 . . . . 0.0 114.131 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.9 -81.9 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.111 0.965 . . . . 0.0 111.185 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 177.31 -51.37 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.168 2.187 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.83 -45.78 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.545 0.738 . . . . 0.0 111.663 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.175 1.39 . . . . 0.0 111.882 179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 170.81 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 128.42 2.688 . . . . 0.0 111.184 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -64.64 169.52 4.88 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.159 1.384 . . . . 0.0 113.496 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -9.51 99.52 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 129.309 3.044 . . . . 0.0 115.441 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -153.64 70.28 0.83 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.474 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.9 p-90 -167.5 -154.05 0.15 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.382 2.673 . . . . 0.0 110.354 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 81.86 101.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.8 172.5 14.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.187 3.258 . . . . 0.0 112.039 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.83 -50.17 1.24 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.184 0.994 . . . . 0.0 113.632 -176.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 142.76 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 130.921 3.688 . . . . 0.0 112.018 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.4 t -63.47 -35.61 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.551 0.614 . . . . 0.0 110.306 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.253 1.238 0 C-N-CA 127.296 2.238 . . . . 0.0 111.529 169.408 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 111.374 0.139 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 70.35 6.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.621 1.169 . . . . 0.0 111.054 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -160.05 161.23 33.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.666 1.587 . . . . 0.0 112.56 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.36 -32.67 74.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 50.84 54.62 10.9 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.4 p-90 -161.39 -154.87 0.37 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.503 2.321 . . . . 0.0 111.035 -168.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 76.46 86.3 0.08 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -86.45 -23.3 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.302 2.668 . . . . 0.0 114.639 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -72.58 -69.64 0.39 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 57.42 34.4 24.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.835 1.654 . . . . 0.0 112.935 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.09 -39.42 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.899 0.88 . . . . 0.0 110.959 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 126.172 1.789 . . . . 0.0 113.686 172.084 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -164.03 -57.94 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.069 1.347 . . . . 0.0 111.516 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -87.42 164.59 16.11 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.952 1.301 . . . . 0.0 112.356 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.24 -0.67 57.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.112 1.365 . . . . 0.0 114.297 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -147.49 92.26 2.07 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.5 p-90 -137.45 -151.01 0.38 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.531 2.332 . . . . 0.0 111.178 -169.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -164.99 56.62 0.12 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 -49.22 2.3 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.178 1.918 . . . . 0.0 112.31 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 tp -175.97 116.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.049 2.14 . . . . 0.0 108.72 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -71.78 -15.95 62.18 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.8 -24.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.891 1.276 . . . . 0.0 111.857 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.477 1.911 . . . . 0.0 113.091 -175.818 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 76.77 -51.04 0.57 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 128.574 2.75 . . . . 0.0 112.881 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.29 -32.19 0.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.932 2.893 . . . . 0.0 115.529 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.31 -29.99 70.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.16 1.384 . . . . 0.0 114.388 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 61.21 51.99 4.11 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.5 p-90 -163.63 -156.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.022 2.529 . . . . 0.0 110.481 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 68.7 97.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.36 157.61 37.05 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.312 2.674 . . . . 0.0 111.529 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.7 tp -152.43 -94.88 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.799 1.239 . . . . 0.0 109.406 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -172.7 -46.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.864 1.666 . . . . 0.0 112.84 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.89 -35.34 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.841 0.856 . . . . 0.0 112.546 -174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 126.854 2.062 . . . . 0.0 114.642 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.293 36.7 ptt180 43.19 40.35 2.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.817 2.447 . . . . 0.0 117.086 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -132.91 38.48 3.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.26 1.824 . . . . 0.0 112.591 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 79.68 -4.29 1.98 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.378 2.671 . . . . 0.0 115.238 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 67.39 50.57 0.94 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.2 p-90 -163.25 -151.11 0.17 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.45 2.3 . . . . 0.0 111.172 -171.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 74.52 -59.15 0.56 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.46 -53.48 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.891 2.394 . . . . 0.0 111.777 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.2 107.44 0.51 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 108.734 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -101.99 23.59 11.28 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.586 1.554 . . . . 0.0 112.641 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t 90.44 -20.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 130.141 3.376 . . . . 0.0 111.462 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.452 1.901 . . . . 0.0 114.177 178.175 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.523 -0.275 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -134.66 136.37 42.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.665 1.586 . . . . 0.0 111.436 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -129.8 59.0 1.62 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.837 1.655 . . . . 0.0 111.555 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.69 69.96 0.45 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.474 1.91 . . . . 0.0 113.105 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 57.96 47.72 14.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 3.3 p-90 -162.21 -157.4 0.47 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.069 2.548 . . . . 0.0 110.69 -170.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -51.59 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.04 123.12 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.539 2.826 . . . . 0.0 111.408 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' H ' ' A' ' 17' ' ' ASN . 16.7 mt -117.54 -93.46 0.51 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.65 1.18 . . . . 0.0 108.712 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 4.2 t30 -166.85 47.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.159 2.583 . . . . 0.0 109.706 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.92 -26.08 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.28 -0.888 . . . . 0.0 111.875 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.239 1.416 . . . . 0.0 112.921 -176.247 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -66.34 140.71 58.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.352 1.061 . . . . 0.0 112.874 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -163.62 -49.67 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.494 1.918 . . . . 0.0 112.585 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.99 -30.8 9.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.943 1.297 . . . . 0.0 113.984 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -137.03 63.51 1.56 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 2.6 p-90 -163.15 -124.31 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.885 2.074 . . . . 0.0 110.882 -169.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 104.75 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.81 -37.5 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.031 2.487 . . . . 0.0 113.667 -170.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp 73.74 112.45 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.066 2.546 . . . . 0.0 111.339 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -109.32 25.23 12.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -65.81 -36.29 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.365 1.866 . . . . 0.0 111.591 -177.325 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 70.01 -48.32 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 128.64 2.776 . . . . 0.0 114.571 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -139.78 32.27 2.02 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.652 1.581 . . . . 0.0 113.304 -170.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . 95.35 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.741 3.616 . . . . 0.0 111.657 -174.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 6' ' ' VAL . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -134.66 58.21 1.78 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 2.8 p-90 -167.8 -153.82 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.236 2.614 . . . . 0.0 110.44 -169.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -74.46 76.49 1.93 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.04 -57.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.93 2.42 . . . . 0.0 113.207 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -164.89 -56.64 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.019 0.928 . . . . 0.0 111.792 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 64.36 55.43 1.41 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.716 1.606 . . . . 0.0 112.05 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.51 -41.82 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.076 0.95 . . . . 0.0 111.054 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.532 1.933 . . . . 0.0 113.219 175.675 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -109.73 143.85 38.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.372 1.469 . . . . 0.0 111.229 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.48 -41.38 39.7 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.174 0.59 . . . . 0.0 112.5 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -100.0 168.14 10.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.957 1.303 . . . . 0.0 111.365 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -134.68 48.76 2.28 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 5.6 p-90 -160.14 -157.31 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.703 2.401 . . . . 0.0 110.97 -172.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -48.98 107.66 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.59 -23.75 5.68 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.549 2.833 . . . . 0.0 114.154 -169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.43 -126.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.148 1.779 . . . . 0.0 108.387 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -52.57 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.073 1.749 . . . . 0.0 112.318 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.25 -34.67 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.67 1.188 . . . . 0.0 111.837 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.346 1.859 . . . . 0.0 111.902 -171.031 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 110.625 -0.139 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 4.5 p-90 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.474 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.9 p-90 . . . . . 0 CA--C 1.55 0.962 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.4 p-90 . . . . . 0 CA--C 1.555 1.158 0 N-CA-C 111.035 0.013 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 . . . . . 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.5 p-90 . . . . . 0 CA--C 1.551 0.989 0 CA-C-O 119.958 -0.067 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 . . . . . 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.5 p-90 . . . . . 0 CA--C 1.551 0.998 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 . . . . . 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.2 p-90 . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 3.3 p-90 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 110.69 -0.115 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 2.6 p-90 . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.045 0.45 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 6' ' ' VAL . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 . . . . . 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 2.8 p-90 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 111.365 0.135 . . . . 0.0 111.365 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 5.6 p-90 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.97 -0.011 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 119.463 -0.303 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -80.64 -54.04 6.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.298 1.039 . . . . 0.0 112.865 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -91.91 -40.52 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.319 1.047 . . . . 0.0 112.51 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -115.32 156.21 25.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.985 1.714 . . . . 0.0 110.625 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.27 -48.35 25.39 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.695 -0.628 . . . . 0.0 112.452 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 -41.04 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.902 1.281 . . . . 0.0 114.344 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.53 -89.7 0.13 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.181 1.372 . . . . 0.0 111.411 -169.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -141.29 58.4 1.52 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 112.693 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.492 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 4.5 p-90 -159.97 -104.12 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.34 2.656 . . . . 0.0 109.142 -169.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -117.08 -30.11 5.76 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 169.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.69 174.48 0.12 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 128.838 2.855 . . . . 0.0 116.002 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t30 70.54 76.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.001 2.121 . . . . 0.0 111.34 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.1 -23.48 33.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.612 2.208 . . . . 0.0 114.131 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.9 -81.9 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.111 0.965 . . . . 0.0 111.185 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 177.31 -51.37 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.168 2.187 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.83 -45.78 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.545 0.738 . . . . 0.0 111.663 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.175 1.39 . . . . 0.0 111.882 179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 170.81 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 128.42 2.688 . . . . 0.0 111.184 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -64.64 169.52 4.88 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.159 1.384 . . . . 0.0 113.496 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -9.51 99.52 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 129.309 3.044 . . . . 0.0 115.441 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.42 -29.2 66.41 Favored Glycine 0 N--CA 1.481 1.653 0 O-C-N 121.154 -0.967 . . . . 0.0 113.71 -169.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -57.88 -28.95 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.795 2.038 . . . . 0.0 114.498 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.15 -89.31 0.27 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 127.279 2.371 . . . . 0.0 107.415 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -153.64 70.28 0.83 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.585 1.554 . . . . 0.0 109.134 169.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.474 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.9 p-90 -167.5 -154.05 0.15 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.382 2.673 . . . . 0.0 110.354 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.44 -42.22 96.12 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 120.687 -1.258 . . . . 0.0 114.1 -175.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 58.36 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.821 2.848 . . . . 0.0 116.589 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t30 81.86 101.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.535 2.734 . . . . 0.0 111.233 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.8 172.5 14.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.187 3.258 . . . . 0.0 112.039 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.83 -50.17 1.24 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.184 0.994 . . . . 0.0 113.632 -176.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 142.76 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 130.921 3.688 . . . . 0.0 112.018 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.4 t -63.47 -35.61 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.551 0.614 . . . . 0.0 110.306 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.253 1.238 0 C-N-CA 127.296 2.238 . . . . 0.0 111.529 169.408 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 111.374 0.139 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 70.35 6.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.621 1.169 . . . . 0.0 111.054 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -160.05 161.23 33.89 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.666 1.587 . . . . 0.0 112.56 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.36 -32.67 74.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.43 46.59 76.55 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 124.417 1.008 . . . . 0.0 112.978 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -168.64 -46.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.859 1.263 . . . . 0.0 113.558 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.06 0.21 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 125.492 1.52 . . . . 0.0 113.288 -172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 50.84 54.62 10.9 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.751 2.021 . . . . 0.0 114.32 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.4 p-90 -161.39 -154.87 0.37 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.503 2.321 . . . . 0.0 111.035 -168.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.51 -39.31 93.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.42 159.02 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.974 2.91 . . . . 0.0 115.541 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t30 76.46 86.3 0.08 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.599 2.36 . . . . 0.0 111.912 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -86.45 -23.3 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.302 2.668 . . . . 0.0 114.639 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -72.58 -69.64 0.39 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -169.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 57.42 34.4 24.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.835 1.654 . . . . 0.0 112.935 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.09 -39.42 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.899 0.88 . . . . 0.0 110.959 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.255 1.39 0 C-N-CA 126.172 1.789 . . . . 0.0 113.686 172.084 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -164.03 -57.94 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.069 1.347 . . . . 0.0 111.516 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -87.42 164.59 16.11 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.952 1.301 . . . . 0.0 112.356 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.24 -0.67 57.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.112 1.365 . . . . 0.0 114.297 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.46 27.43 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.359 0.981 . . . . 0.0 112.756 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -179.42 -50.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.66 1.984 . . . . 0.0 112.109 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.04 -92.87 0.16 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 106.849 -2.5 . . . . 0.0 106.849 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -147.49 92.26 2.07 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 117.59 0.695 . . . . 0.0 112.332 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.5 p-90 -137.45 -151.01 0.38 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.531 2.332 . . . . 0.0 111.178 -169.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -71.02 -28.28 64.29 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 53.9 71.53 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.644 2.377 . . . . 0.0 114.868 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -164.99 56.62 0.12 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.195 0.998 . . . . 0.0 112.18 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.88 -49.22 2.3 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.178 1.918 . . . . 0.0 112.31 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 tp -175.97 116.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.049 2.14 . . . . 0.0 108.72 172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -71.78 -15.95 62.18 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.8 -24.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.891 1.276 . . . . 0.0 111.857 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.477 1.911 . . . . 0.0 113.091 -175.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 76.77 -51.04 0.57 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 128.574 2.75 . . . . 0.0 112.881 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.29 -32.19 0.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 128.932 2.893 . . . . 0.0 115.529 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.31 -29.99 70.83 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.16 1.384 . . . . 0.0 114.388 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.33 27.96 60.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.066 0.841 . . . . 0.0 114.104 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.27 -120.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 125.855 1.662 . . . . 0.0 108.24 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.91 37.08 2.06 Favored Glycine 0 N--CA 1.474 1.179 0 C-N-CA 127.256 2.36 . . . . 0.0 112.276 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 61.21 51.99 4.11 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.085 1.754 . . . . 0.0 111.896 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 3.5 p-90 -163.63 -156.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.022 2.529 . . . . 0.0 110.481 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -65.82 -36.05 82.41 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 58.43 171.98 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.206 2.602 . . . . 0.0 115.827 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 68.7 97.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.103 2.561 . . . . 0.0 111.777 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.36 157.61 37.05 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.312 2.674 . . . . 0.0 111.529 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.7 tp -152.43 -94.88 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.799 1.239 . . . . 0.0 109.406 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -172.7 -46.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.864 1.666 . . . . 0.0 112.84 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.89 -35.34 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.841 0.856 . . . . 0.0 112.546 -174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 126.854 2.062 . . . . 0.0 114.642 -178.331 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 119.78 -0.152 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.293 36.7 ptt180 43.19 40.35 2.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.817 2.447 . . . . 0.0 117.086 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -132.91 38.48 3.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 126.26 1.824 . . . . 0.0 112.591 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 79.68 -4.29 1.98 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.378 2.671 . . . . 0.0 115.238 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.09 20.28 61.18 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.943 1.259 . . . . 0.0 113.147 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.96 -33.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.633 1.573 . . . . 0.0 114.779 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.34 41.5 1.05 Allowed Glycine 0 N--CA 1.476 1.345 0 C-N-CA 124.476 1.036 . . . . 0.0 113.114 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.251 39.3 mt-30 67.39 50.57 0.94 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 126.611 1.964 . . . . 0.0 114.267 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 5.2 p-90 -163.25 -151.11 0.17 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.45 2.3 . . . . 0.0 111.172 -171.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -70.66 -34.66 72.26 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.663 -1.273 . . . . 0.0 114.112 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 58.4 -163.09 0.21 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.754 2.422 . . . . 0.0 114.729 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 t30 74.52 -59.15 0.56 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.714 2.806 . . . . 0.0 113.882 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.46 -53.48 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.891 2.394 . . . . 0.0 111.777 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.2 107.44 0.51 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 108.734 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -101.99 23.59 11.28 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.586 1.554 . . . . 0.0 112.641 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t 90.44 -20.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 130.141 3.376 . . . . 0.0 111.462 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.452 1.901 . . . . 0.0 114.177 178.175 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.523 -0.275 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -134.66 136.37 42.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.665 1.586 . . . . 0.0 111.436 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -129.8 59.0 1.62 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.837 1.655 . . . . 0.0 111.555 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.69 69.96 0.45 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.474 1.91 . . . . 0.0 113.105 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -19.78 62.52 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 125.634 1.588 . . . . 0.0 113.558 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -49.69 -28.5 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 127.044 2.138 . . . . 0.0 113.544 168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.03 1.58 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.338 1.923 . . . . 0.0 113.179 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 57.96 47.72 14.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.733 1.613 . . . . 0.0 112.947 -173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.48 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 3.3 p-90 -162.21 -157.4 0.47 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.069 2.548 . . . . 0.0 110.69 -170.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -64.0 -35.83 82.0 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.781 -1.199 . . . . 0.0 114.083 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 61.38 -61.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.312 3.045 . . . . 0.0 115.63 -173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -51.59 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.192 1.797 . . . . 0.0 113.713 -170.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.04 123.12 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.539 2.826 . . . . 0.0 111.408 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' H ' ' A' ' 17' ' ' ASN . 16.7 mt -117.54 -93.46 0.51 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.65 1.18 . . . . 0.0 108.712 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 4.2 t30 -166.85 47.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.159 2.583 . . . . 0.0 109.706 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.92 -26.08 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.28 -0.888 . . . . 0.0 111.875 -175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.255 1.359 0 C-N-CA 125.239 1.416 . . . . 0.0 112.921 -176.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -66.34 140.71 58.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.352 1.061 . . . . 0.0 112.874 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -163.62 -49.67 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.494 1.918 . . . . 0.0 112.585 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.99 -30.8 9.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.943 1.297 . . . . 0.0 113.984 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.32 33.06 49.92 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.223 0.916 . . . . 0.0 113.277 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.67 -57.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.893 1.677 . . . . 0.0 112.268 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.7 -96.67 0.15 Allowed Glycine 0 N--CA 1.469 0.89 0 C-N-CA 126.13 1.824 . . . . 0.0 109.799 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -137.03 63.51 1.56 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.749 0.819 . . . . 0.0 111.649 169.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CE3' ' HG3' ' A' ' 11' ' ' LYS . 2.6 p-90 -163.15 -124.31 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.885 2.074 . . . . 0.0 110.882 -169.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -101.71 -24.22 14.11 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 58.39 179.2 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.6 2.76 . . . . 0.0 116.223 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 t30 104.75 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 131.223 3.809 . . . . 0.0 112.779 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.81 -37.5 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.031 2.487 . . . . 0.0 113.667 -170.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 tp 73.74 112.45 0.06 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.066 2.546 . . . . 0.0 111.339 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -109.32 25.23 12.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -65.81 -36.29 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.365 1.866 . . . . 0.0 111.591 -177.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.604 -0.712 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 70.01 -48.32 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 128.64 2.776 . . . . 0.0 114.571 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -139.78 32.27 2.02 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.652 1.581 . . . . 0.0 113.304 -170.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . 95.35 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.741 3.616 . . . . 0.0 111.657 -174.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.37 31.04 9.18 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 125.731 1.634 . . . . 0.0 112.83 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -158.49 -125.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 126.674 1.99 . . . . 0.0 107.381 -169.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 6' ' ' VAL . . . -102.77 -96.27 2.34 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 169.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -134.66 58.21 1.78 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.307 1.043 . . . . 0.0 110.176 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.518 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 2.8 p-90 -167.8 -153.82 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.236 2.614 . . . . 0.0 110.44 -169.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 ptmt -65.17 -38.74 91.48 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.525 -1.359 . . . . 0.0 114.634 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.92 -28.23 0.17 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.842 3.257 . . . . 0.0 116.91 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -74.46 76.49 1.93 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 120.011 1.278 . . . . 0.0 114.244 -172.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.04 -57.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.93 2.42 . . . . 0.0 113.207 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -164.89 -56.64 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.019 0.928 . . . . 0.0 111.792 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 64.36 55.43 1.41 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.716 1.606 . . . . 0.0 112.05 171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.51 -41.82 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.076 0.95 . . . . 0.0 111.054 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.532 1.933 . . . . 0.0 113.219 175.675 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -109.73 143.85 38.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.372 1.469 . . . . 0.0 111.229 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.48 -41.38 39.7 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.174 0.59 . . . . 0.0 112.5 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -100.0 168.14 10.04 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.957 1.303 . . . . 0.0 111.365 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.25 41.43 1.33 Allowed Glycine 0 N--CA 1.48 1.57 0 C-N-CA 125.191 1.377 . . . . 0.0 113.437 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -166.09 -42.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 128.539 2.736 . . . . 0.0 111.929 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.09 -109.33 0.43 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 106.9 -2.48 . . . . 0.0 106.9 -170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -134.68 48.76 2.28 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.692 1.197 . . . . 0.0 111.331 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 5.6 p-90 -160.14 -157.31 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.703 2.401 . . . . 0.0 110.97 -172.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -62.55 -35.88 80.87 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.707 -1.246 . . . . 0.0 113.936 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 59.49 -65.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 128.879 2.872 . . . . 0.0 115.483 -173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -48.98 107.66 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.657 1.583 . . . . 0.0 113.18 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.59 -23.75 5.68 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.549 2.833 . . . . 0.0 114.154 -169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.43 -126.67 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.148 1.779 . . . . 0.0 108.387 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -52.57 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.073 1.749 . . . . 0.0 112.318 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.25 -34.67 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.67 1.188 . . . . 0.0 111.837 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.346 1.859 . . . . 0.0 111.902 -171.031 . . . . . . . . 0 0 . 1 stop_ save_